Incyte

Yahoo Finance • yesterday

Notable healthcare headlines for the week: UnitedHealth, Eli Lilly, Pfizer in focus

Wall Street’s major averages ended mostly lower on Friday, as market participants have been keeping an eye on the highly anticipated meeting between Donald Trump and Vladimir Putin. However, the S&P 500 Health Care Index Sector (NYSEARCA:... Full story

Yahoo Finance • 3 days ago

Cancer Stock Soars While This China Tech Stock Heads To New Highs

Cancer stock Incyte soared on earnings and touched a new high on Friday. Also at new highs, Lidar maker Hesai group shows ideal relative strength. Continue Reading View Comments... Full story

Yahoo Finance • 3 days ago

Saudi Arabia Flavors and Fragrances Industry Research 2025 | Market Trends, Regional Insights, Competition, Forecast & Opportunities, 2020-2030 - Natural and Clean-Label Trends Drive Expansion

Dublin, Aug. 15, 2025 (GLOBE NEWSWIRE) -- The "Saudi Arabia Flavors and Fragrances Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" report has been added to ResearchAndMarkets.com's offering. The Saudi Arabia Fla... Full story

Yahoo Finance • 4 days ago

Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

New York, USA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight The vitiligo treatment landscape is evolving with a shift tow... Full story

Yahoo Finance • 5 days ago

Sotera Health Company, Incyte, Exact Sciences, Bausch + Lomb, and Addus HomeCare Shares Skyrocket, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer Price Index (CPI) report,... Full story

Yahoo Finance • 5 days ago

From tech to retail: PLTR and EBAY are among the top 10 most overbought stocks

[Sustainability investment in 2024] primeimages Wall Street’s rally has pushed a notable slice of the S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500]) into technically overbought territory, underscoring the market’s strong momentum... Full story

Yahoo Finance • 6 days ago

Wells Fargo Upgrades Incyte Corporation (INCY) to Overweight From Equal Weight

Incyte Corporation (NASDAQ:INCY) is one of the top most undervalued biotech stocks to buy now. Wells Fargo upgraded Incyte Corporation (NASDAQ:INCY) to Overweight from Equal Weight on August 6, raising the price target to $89 from $67.Incy... Full story

Yahoo Finance • 6 days ago

Vitiligo Treatment Strategic Market Research Report 2025-2030 | Increased Psychological and Social Impact of Vitiligo Drives Demand for More Effective Therapies

Dublin, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The "Vitiligo Treatment - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Vitiligo Treatment was estimated at US$1.5 Billion in 20... Full story

Yahoo Finance • 8 days ago

Gilead Sciences Is Closing In on an All-Time High. The Case for More Upside.

While Celgene was absorbed by Bristol Myers in early 2019, Gilead Sciences has emerged as the enduring standout among the remaining trio. Gilead has surged 59% and offers a healthy 2.6% dividend yield, while Amgen and Biogen have declined... Full story

Yahoo Finance • 13 days ago

Incyte Announces Departure of Chief Financial Officer Christiana Stamoulis

- Company initiates search for successor and reaffirms full year financial guidance WILMINGTON, Del., August 05, 2025--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) today announced that Christiana Stamoulis will step down from her role as Executi... Full story

Yahoo Finance • 18 days ago

Knight Therapeutics Announces Regulatory Supplemental Submission of MINJUVI® (tafasitamab) for Follicular Lymphoma in Brazil

MONTREAL, July 31, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltda., has submitted a sup... Full story

Yahoo Finance • 18 days ago

Thérapeutique Knight annonce la soumission réglementaire supplémentaire de MINJUVI® (tafasitamab) pour le traitement du lymphome folliculaire au Brésil

MONTRÉAL, 31 juill. 2025 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight »), société pharmaceutique spécialisée panaméricaine (hors États-Unis), a annoncé aujourd’hui que sa filiale brésilienne, United Medical Ltda, a... Full story

Yahoo Finance • 20 days ago

Top S&P500 movers in Tuesday's session

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights. [topmovers] TOP GAINERS TICKER CHANGE COMME... Full story

Yahoo Finance • 20 days ago

Which S&P500 stocks are moving before the opening bell on Tuesday?

Stay updated with the S&P500 stocks that are on the move in today's pre-market session. [premarket] GAINERS TICKER CHANGE COMMENT CDNS [https://www.chartmill.com/stock/quote/CDNS/profile] 8.16% CADENCE DESIGN SYS INC'S (N... Full story

Yahoo Finance • last month

Incyte EVP Flannelly sells $83k in shares

Incyte (NASDAQ:INCY) Executive Vice President and General Manager US, Barry P. Flannelly, sold 1,192 shares of company stock on July 15, 2025, at a price of $69.86, totaling approximately $83,273. The transaction comes as the $13.4 billion... Full story

Yahoo Finance • last month

William Blair Maintains ‘Hold’ Rating on Incyte Corporation (INCY), Citing Future Revenue Uncertainties

Incyte Corporation (NASDAQ:INCY) is one of the 10 Best Cheap Stocks to Buy According to Billionaire Ray Dalio. Bridgewater Associates holds over $38 million worth of shares of INCY, which represents 0.18% of its portfolio.William Blair Mai... Full story

Yahoo Finance • last month

Notable healthcare headlines for the week: Novo Nordisk, Eli Lilly, AbbVie and Centene in focus

Wall Street notched another record close on Thursday, as market participants snapped up equities and dumped bonds after nonfarm payrolls jumped more than expected in June. The S&P 500 Health Care Index Sector (NYSEARCA:XLV [https://seekin... Full story

Yahoo Finance • 2 months ago

BTIG reiterates Buy rating on VYNE Therapeutics stock ahead of vitiligo trial data

Investing.com - BTIG has reiterated its Buy rating and $5.00 price target on VYNE Therapeutics (NASDAQ:VYNE), currently trading at $1.51 with a market cap of $25.2 million. InvestingPro data shows analysts maintain a strong buy consensus w... Full story

Yahoo Finance • 2 months ago

Jim Cramer Highlights That Incyte’s New CEO is an “Industry Veteran”

Incyte Corporation (NASDAQ:INCY) is one of the top 10 S&P 500 winners of the day that Jim Cramer highlighted. Cramer appreciated the new CEO of the company, as he commented: “We then have Incyte. That’s a biotech company. It just got a ne... Full story

Yahoo Finance • 2 months ago

Shell denies deal talks with BP, Micron reports Q3 beat: Morning Buzz

The major averages were higher near noon, with the S&P 500 continuing its path towards all-time highs reached earlier this year. Meanwhile, the U.S. dollar is under pressure amid the worst first-half performance in 50 years, falling to its... Full story